Literature DB >> 1985506

Comparison of percutaneous losses of sevoflurane and isoflurane in humans.

S H Lockhart1, N Yasuda, N Peterson, M Laster, S Taheri, R B Weiskopf, E I Eger.   

Abstract

We studied the percutaneous losses of sevoflurane and isoflurane during administration and elimination in seven healthy male volunteers. Anesthesia was induced and maintained with fentanyl, midazolam, and/or thiopental, and nitrous oxide for 30 min, after which 1% sevoflurane and 0.4% isoflurane in 65% nitrous oxide were administered for 30 min. Inspired, end-tidal, and mixed-expired gas samples were collected during administration and for 5-7 days of elimination. To measure percutaneous loss, each subject's arm was enclosed in a glass cylinder sealed at both ends and with two ports, one for flushing with nitrogen and one for obtaining gas samples during the 30 min of administration and the first 150 min of elimination. Anesthetic concentrations in all samples were determined using gas chromatography. The surface area of the arm was measured and the total surface area was calculated. During administration and elimination, percutaneous loss of isoflurane was significantly greater than that of sevoflurane (P less than 0.05). For both volatile agents, losses during elimination were greater than during administration (P less than 0.05), but even when combined, these losses were too small to affect kinetic or metabolic studies based on mass balance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985506     DOI: 10.1213/00000539-199102000-00013

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

Review 1.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

2.  Pharmacokinetics of sevoflurane elimination from respiratory gas and blood after coronary artery bypass grafting surgery.

Authors:  Chih-Cherng Lu; Lin Tso-Chou; Che-Hao Hsu; Chien-Song Tsai; Michael J Sheen; Oliver Yao-Pu Hu; Shung-Tai Ho
Journal:  J Anesth       Date:  2014-05-07       Impact factor: 2.078

Review 3.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

Review 4.  Sevoflurane.

Authors:  Stefan De Hert; Anneliese Moerman
Journal:  F1000Res       Date:  2015-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.